About Genor
about us

Genor Biopharma Co. Ltd (“Genor”) is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs. Genor has successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally. Genor has leveraged primarily in-house capabilities in establishing a pipeline of 15 targeted drug candidates with tremendous commercialization potentials in China that cover both proven and novel biological pathways.

Genors leadership team boasts more than 15 years of industry experience on average with proven track record and a well-balanced combination of expertise. Genor currently has around 400 employees across 3 sites in China - Shanghai Zhangjiang, Yunnan Yuxi, and Beijing office, as well as lab in South San Francisco, US, among which 80% are R&D and clinical specialists.


Beijing office

Yuxi, Yunnan - Principally Phase 3 and commercial manufacturing

Zhangjiang, Shanghai - R&D center, QC/Analytical center, cGMP sample manufacturing

South San Francisco, US - Bi-specific platform

open quote
close quote
Our Vision

We aspire to become a biopharmaceutical company with global presence, serving patients and society.

open quote
close quote
Our Mission

Our mission is to become a biopharmaceutical engine in discovery, research, development, manufacturing and commercialization of innovative therapeutics initially for patients in China and gradually for patients globally.

Our History